VIVUS Inc (VVUS)

Add to Watchlists
Create an Alert
4.18 -0.11  -2.56% NASDAQ Mar 25, 20:00 Delayed 2m USD
View Full Chart
VVUS Price Chart
View All Events

VVUS Events

Date Type Description
06/05/2019 Misc VIVUS Inc Annual General Meeting in 2018
05/08/2019 16:30 EDT Misc VIVUS Inc First Quarter Earnings Conference Call in 2019
05/08/2019 Earnings VIVUS Inc First Quarter Earnings in 2019 Release
02/26/2019 16:30 EST Misc VIVUS Inc Fourth Quarter Earnings Conference Call in 2018
02/26/2019 Earnings VIVUS Inc Fourth Quarter Earnings in 2018 Release
11/01/2018 16:30 EDT Misc VIVUS Inc Third Quarter Earnings Conference Call in 2018
11/01/2018 Earnings VIVUS Inc Third Quarter Earnings in 2018 Release
09/11/2018 Splits Ratio: 1:10
09/07/2018 Misc VIVUS Inc Annual General Meeting in 2017
08/07/2018 16:30 EDT Misc VIVUS Inc Second Quarter Earnings Conference Call in 2018
View All Performance Charts

VVUS Total Returns Comparison

Advertisement

VVUS One Page Reports

Edit

Profile

  • URL: http://www.vivus.com
  • Investor Relations URL: http://ir.vivus.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: May. 08, 2019
  • Last Earnings Release: Feb. 26, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and Stendra/Spedra, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction. The company operates through the single segment of business being Development and commercialization of novel therapeutic products.

VVUS Comparables

Edit

VVUS Excel Add-In Codes

  • Name: =YCI("VVUS","name")
  • Description: =YCI("VVUS","description")
  • Sector: =YCI("VVUS","sector")
  • Industry: =YCI("VVUS","industry")
  • Est. Current Fiscal Year End: =YCI("VVUS","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.